Adverse drug reactions (ADRs) are dangerous and expensive, afflicting about 1.5% of hospitalized patients with profound health and financial consequences. In Medicare patients alone, adverse drug reactions account for 19% of total spending ($339 billion), more than 1,900 deaths, and more than 77,000 extra hospital days per year. Idiosyncratic ADRs, especially rare and severe hypersensitivity-driven ADRs, are the leading cause of medicine withdrawal and termination of clinical development. At the same time, a large proportion of drugs are not associated with hypersensitivity driven ADRs, offering hope that new medicines could avoid them entirely with reliable predictors of risk. Hypersensitivity driven ADRs are caused by the formation of chemically reactive metabolites by metabolic enzymes. These reactive metabolites covalently attach to proteins to become immunogenic and provoke an ADR. Unfortunately, current computational and experimental approaches do not reliably identify drug candidates that form reactive metabolites. These approaches are limited because they inadequately model metabolism, which can both render toxic molecules safe and safe molecules toxic. To overcome this limitation, the proposed study aims to curate a public database of metabolism and reactivity and use this database to build accurate and validated mathematical models of metabolism and reactivity. The models will be constructed using machine-learning algorithms that quantitatively summarize the knowledge from thousands of published studies.
The Aims are to (1) curate a database of metabolism and build models that identify rules governing the structure of reaction products during drug metabolism in the liver, (2) curate a database of reactivity and build improved reactivity models that mechanistically predict which metabolites are reactive with biological molecules, and (3) curate a database of reactive metabolites and combine these models to predict when molecules form reactive metabolites that covalently bind proteins. The computational models generated by these Aims will be validated through statistical approaches and against bench-top experiments. Taken together, this approach will substantially improve on existing approaches by more accurately modeling the properties determining whether metabolism renders drugs toxic or safe. The predictive models will make new medicines safer by helping researchers avoid molecules prone to ADRs without harming patients.

Public Health Relevance

Adverse drug reactions, especially rare but severe hypersensitivity-driven reactions, have profound financial and health implications and are caused by reactive drug metabolites. As an extension of tools and data developed by our groups, we will build and test mathematical models and datasets that more accurately predict when molecules form clinically important reactive metabolites than current methodologies, such as ?structural alerts.? We will use these models to build a tool that will better predict when drug candidates form reactive metabolites, which will make new medicines safer by enabling researchers to avoid drug candidates prone to causing adverse reactions.

National Institute of Health (NIH)
National Library of Medicine (NLM)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZLM1)
Program Officer
Ye, Jane
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Dang, Na Le; Hughes, Tyler B; Miller, Grover P et al. (2018) Computationally Assessing the Bioactivation of Drugs by N-Dealkylation. Chem Res Toxicol 31:68-80
Matlock, Matthew K; Dang, Na Le; Swamidass, S Joshua (2018) Learning a Local-Variable Model of Aromatic and Conjugated Systems. ACS Cent Sci 4:52-62
Barnette, Dustyn A; Davis, Mary A; Dang, Na L et al. (2018) Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approaches. Biochem Pharmacol 156:10-21
Marsh, Jon N; Matlock, Matthew K; Kudose, Satoru et al. (2018) Deep Learning Global Glomerulosclerosis in Transplant Kidney Frozen Sections. IEEE Trans Med Imaging 37:2718-2728
Hartman, Jessica H; Miller, Grover P; Meyer, Joel N (2017) Toxicological Implications of Mitochondrial Localization of CYP2E1. Toxicol Res (Camb) 6:273-289
Dang, Na Le; Hughes, Tyler B; Miller, Grover P et al. (2017) Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes. Chem Res Toxicol 30:1046-1059
Hughes, Tyler B; Swamidass, S Joshua (2017) Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism. Chem Res Toxicol 30:642-656
Ruan, Shuxiang; Swamidass, S Joshua; Stormo, Gary D (2017) BEESEM: estimation of binding energy models using HT-SELEX data. Bioinformatics 33:2288-2295
Barnette, Dustyn A; Johnson, Bryce P; Pouncey, Dakota L et al. (2017) Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases. Drug Metab Dispos 45:1000-1007
Kumar, Runjun D; Swamidass, S Joshua; Bose, Ron (2016) Unsupervised detection of cancer driver mutations with parsimony-guided learning. Nat Genet 48:1288-94

Showing the most recent 10 out of 17 publications